Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer Editorial Comment

被引：0
|
作者：
Montie, James E.
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 03期
关键词：
D O I：
10.1016/j.juro.2009.11.100
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [31] BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Su, Zhuo T.
    Mahon, Katherine
    Rezaee, Michael
    Patel, Sunil
    Townsend, Jeffrey
    Kates, Max
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1169 - E1170
  • [32] No 'one size fits all' approach in the management of high-risk non-muscle invasive bladder cancer
    Mostafid, Hugh
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (01) : 53 - 53
  • [33] High-risk Non-muscle Invasive Bladder Cancer - "The Real Deal" for Blue Light Cystoscopy and TURBT?
    Geavlete, P.
    Geavlete, B.
    Jecu, M.
    Multescu, R.
    Georgescu, D.
    Dragutescu, M.
    BJU INTERNATIONAL, 2010, 106 (01) : 6 - 6
  • [34] HIGH-RISK NMIBC (NON-MUSCLE INVASIVE BLADDER CANCER): PROGNOSTIC VALUE OF CIRCULATING TUMOR CELLS
    De Berardinis, Ettore
    Busetto, Gian Maria
    Petracce, Arianna
    Nicolazzo, Chiara
    Gazzaniga, Paola
    Gentile, Vincenzo
    JOURNAL OF UROLOGY, 2011, 185 (04): : E205 - E206
  • [35] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [36] New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives
    Gomez del Canizo, C.
    Rodriguez-Izquierdo Jimenez, M.
    Pena Vallejo, E.
    Duarte Ojeda, J. M.
    de la Rosa Kehrman, F.
    Rodriguez Antolin, A.
    Guerrero Ramos, F.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (09): : 574 - 585
  • [37] Degree of chromosomal abnormalities detected by UroVysion test predicts progression of non-muscle invasive bladder cancer
    Kocsmar, I.
    Pajor, G.
    Sziraki, A.
    Kocsmar, E.
    Gyongyosi, B.
    Szekely, E.
    Kenessey, I.
    Nyirady, P.
    Kiss, A.
    Schaff, Z.
    Riesz, P.
    Lotz, G.
    VIRCHOWS ARCHIV, 2018, 473 : S189 - S189
  • [38] HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY OR OTHER SUBTYPES NOT A PREDICTOR FOR PROGRESSION IN BCG-TREATED PATIENTS
    Craig, Calkins Daniel
    Facundo, Davaro
    Chris, Guske
    Richard, Sirard, III
    Roger, Li
    Scott, Gilbert
    Wade, Sexton
    Philippe E, Spiess
    Michael, Poch
    Alice, Yu
    Logan, Zemp
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S52 - S52
  • [39] Easily Available Blood Test Neutrophil-To-Lymphocyte Ratio Predicts Progression in High-Risk Non-Muscle Invasive Bladder Cancer
    Martha, Orsolya
    Porav-Hodade, Daniel
    Balan, Daniel
    Tataru, Octavian Sabin
    Sin, Anca
    Chibelean, Calin Bogdan
    Vartolomei, Mihai Dorin
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2017, 25 (02): : 181 - 189
  • [40] The long term outcome of high risk non-muscle invasive bladder cancer
    Thomas, F.
    Rubin, N.
    Goepel, J.
    Abbod, M. F.
    Rosario, D.
    Catto, J. W. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E965 - U26
12345